Apply for the Award

Site: AMEE ESME
Course: ASPIRE submission home
Book: Apply for the Award
Printed by: Guest user
Date: Sunday, 22 December 2024, 10:24 AM

Description


Award Information

This section contains further detail about the ASPIRE 'International Collaborations in Health Professions Education' Award. 

Please take the time to go through this content thoroughly to familiarize yourself with the application criteria and the expert panel involved in the process. Understanding these elements is crucial for a successful application. 

At the end of the content, you will need to fill out the web form to generate the invoice. Completing this form is an essential step in your application process, as it will allow you to proceed with the payment for your selected award. Make sure to provide all the required information to ensure a smooth and efficient processing of your request.

To navigate, use the 'next' and 'back' arrows at the side of the page, or use the Table of Contents to jump to a specific page.

You can also download pdf versions of this guidance and a sample application form for reference.

About the Award

Over the recent years, the need for international collaboration in all sectors has become increasingly vital; we only have to consider the speed at which the new Covid-19 vaccines have been developed and rolled out to appreciate the importance of global collaboration.

In health professions’ education (HPE) too, multiple examples exist of individuals, groups, organisations, and associations collaborating to respond to the crisis and share educational practice. This response includes AMEE, which has provided educational and collaborative support through webinars, specific publications and conference activities.

However, collaboration does not happen only in response to an international crisis: it has a long history in education and healthcare (Ramani et al 2020; McKimm et al 2008). Many examples exist in HPE of international collaborations and the benefits and learning that accrues from these. The literature and practice often conflate the terms ‘partnership’ and ‘collaboration’ and we recognise that what we term ‘collaboration’ for the purpose of the award may be described as a ‘partnership’ by entities, and vice versa. Some collaborations are actual partnerships, such as schools working with international partners to provide student elective and international training opportunities (Waterval et al 2018), curriculum development (Rashid et al 2020) and faculty development. Such partnerships tend to be more transactional, where one partner provides a service for another, either for a fee or other benefit in kind. Whilst we acknowledge the benefits of such activities and the increasing internationalisation of HPE curricula (Wu et al 2020), for this award, we are focusing on collaboration where all entities work together towards common goals and benefits.

For the purposes of the ASPIRE award in International Collaboration, we define collaboration as “the purposeful action of working with others for mutual benefit that extends beyond the organisations themselves and involves a sharing of responsibilities and power”.

Collaborations should be able to demonstrate the additional benefits and value that the collaboration brings, over and above what each entity can achieve alone; some examples are described below.

Collaboration can occur at various levels with wide and varied benefits to multiple stakeholders. Examples include curriculum development in nursing (Didion et al 2013), strengthening research capacity (Noormahomed et al 2018; Hall et al 2016), optimising the reach and impact of interest groups (Walpole et al 2017), linking departments and organisations (Hall et al (2016). It can involve multiple partners or a small number of entities. For example, Walpole et al (2017) report how an international collaboration worked successfully to build an environmentally accountable medical curriculum. Since this publication, this collaboration has been expanded to develop a consensus statement on Education for Sustainable Healthcare (ESH) (Shaw et al., 2021), a special issue in Medical Teacher on ESH in September 2020, established an AMEE Special Interest Group, and carried out several additional activities on planetary health with international groups, including student associations. Another collaboration on Medicine and the Humanities between universities in Canada, China and France was established to develop shared resources, faculty and student exchange and shared learning experiences (see https://med.uottawa.ca/department- innovation/medicine-humanities/international- collaboration).

In East Africa, Yarmoshuk et al (2016) mapped international university partnerships aimed at strengthening medicine, nursing and public health programmes and found 129 university-to- university partnerships from 23 countries. Each university reported between 25 and 36 international university partners. A later study exploring reciprocity between the entities found that, although exchanges were often unequal in terms of financial benefits, the sharing of values, ways of working and cocreating the terms of the partnerships were valued highly by all entities (Yamoshuk et al 2020).

Universities highly value collaborations with international partners and this is reflected in the QS World University Rankings (https://www.topuniversities.com/qs-world-university- rankings), with international collaboration as one of the key criteria; there is huge impetus for universities to encourage and support collaboration. Much international collaboration has involved developing common accreditation standards e.g., for continuous professional development (McMahon et al 2016) and standards and outcomes for undergraduate and postgraduate training programmes, for example in the Caribbean region (van Zanten et al 2009). Such collaborations have greatly improved the quality of HPE in many countries, facilitated the ability of practitioners to live and work around the world, and improved healthcare in underserved regions. As organisations recognise the value of bringing scientists, educators, researchers, and practitioners together for research and development, academic, health science and healthcare partnerships have also proliferated (DeBoer et al 2019; Phillips et al 2004). Whilst many of these are collaborations within a region or country, international collaborations can have huge impact, such as during the Covid-19 pandemicwith not only the development of treatments and production of vaccines, but also in the improvement of training and education, e.g., in surgery (Riviello et al 2010), cancer care (Meade et al 2011), Obstetrics and gynaecology (Anderson & Johnson 2015) and HIV prevention (Dill et al 2020).

International collaborations often intentionally occur between partners in the Global South and Global North aiming to address global inequities in health and educational capacity (Farmer, 2016). Many international collaborations are therefore operating in a broad context of inequity in which power may be unequally held by constituent individual and institutions (Eichbaum et al,. 2021). Development of equitable, ethical collaborations can be challenging precisely because they are occurring in a context of historical and cultural inequality. When opportunity or privilege between partners is uneven (one-sided) collaborations can pose ethical problems and can entrench inequality (Kraeker and Chandler 2013).

In summary, a large body of evidence exists about the value of international collaboration in health professions’ education which provided an impetus for developing this ASPIRE Award. 

Expert Panel

  • Chinthaka Balasooriya (Chair), Australia
  • Samar Absoulsoud, Egypt
  • Emmaline Brouwer, the Netherlands
  • Russell D’Souza, Australia
  • Alaa Dafallah, Sudan
  • Molly Fyfe, USA
  • Lionel Green-Thompson, South Africa
  • Judy McKimm, UK
  • Azhar Adam Nadkar, South Africa
  • Pat O’Sullivan, USA
  • Mohammed Hassan Taha, UAE
  • David Taylor, UAE

Prospective applicants are strongly encouraged to contact the panel chair for an informal discussion before beginning their application. The examples provided by the reviewers are shown below under the respective criteria. These examples are intended to be indicative and not exhaustive. You may have other evidence that would be equally important and which support your case for excellence. 

Criterion 1

Goals and alignment

The collaboration has clear goals that align with those of the representative entities, is based upon previous research or mutual need and designed to improve healthcare educational practice, leadership and/or scholarship and incorporates perspectives and inputs from all members of the collaboration that transparently address issues of power and privilege.

Sub Criteria

Example of Evidence

1.1 There is alignment within and across the entities involved in the collaboration.

Provide the aims and goals of the collaborating entities, explain how these were developed collaboratively and how they were aligned with the various entities’ aims and goals. Indicate how motivations, values and beliefs have been addressed.

1.2 Perspectives from all collaborators are incorporated  in the collaboration

Narrative description of the kinds of design elements included in the collaboration to assure mutual perspectives. Identify differences among the collaborators and how barriers are addressed. This can include how transparent conversations about power, privilege and position are part of the collaboration.

1.3 All collaborators and their stakeholders derive mutual benefits from the collaboration such that there is an influence on healthcare educational practice, leadership and/or scholarship.

Narrative description of the benefits (intended or unintended) specifically describing why the collaboration facilitated these benefits. (e.g., compare with outcomes if each entity worked independently). There should be a description of the benefits from all partners, and they can include tangible products and intangible around education, independence, culture.


These examples are provided by reviewers and are intended to be indicative rather than exhaustive. You may have other evidence that would be equally important and which support your case for excellence. 

Criterion 2

Success of the collaboration

The collaboration employs approaches that optimise the success of the collaboration.

Cite any leadership/collaboration/change models if utilised.

Sub Criteria

Example of Evidence

2.1 Communication mechanisms facilitate collaboration

Describe the types of tools that sustain communication across the collaborators, e.g., minutes, agendas, calls, visits, videoconferencing. If an Memorandum of understanding, contract or other agreement exists this may be included, but is not essential.

2.2 The collaboration has engaged appropriate members to facilitate success

Narrative describes how team members were selected, how roles and expectations are set, and the organization for regular communications. An option could be to include a table or appendix of members and provide the rationale for their participation.

2.3 The collaboration periodically reviews the purpose, goals, and mission to assure that all perspectives are mutually addressed.

Narrative description of how trust is built among the collaborators and opportunities for examining the effectiveness of the collaboration functioning. This might include evidence from annual program review, retreats.

2.4 The collaborators openly explore and document any imbalances of power, including perceived or potential imbalances while ensuring that expectations are met from each partner institutions.

Description of the issues that were considered and measures put in place to address any issues that may arise. May add a reflection on whether such issues arose during the collaboration and how they were addressed while maintaining meeting expectations and mutual benefits to both sides. One may conclude with lessons learned and recommendations for future collaborations.


These examples are provided by reviewers and are intended to be indicative rather than exhaustive. You may have other evidence that would be equally important and which support your case for excellence.

Criterion 3

Institutional issues around collaboration


Sub Criteria

Example of Evidence

3.1 Recruitment, promotion and employment statuses support individuals who participate in collaborative group activities

Narrative that describes how committees will consider educational, research, authorship and journals in publications from collaborative activities and groups, as well as those from individuals. Indicate how the institutional perspective supports the leadership involved in collaborations.

3.2 Commitment to the collaboration is valued and rewarded – ‘reward’ being a wider definition than simply monetary

Narrative of indications of commitment valued across partners as well as the types of recognition given to the collaboration/collaborators. Mechanisms to generate support from the wider leadership of collaborating entities, for example but not limited to, aligning with institutional strategic priorities.


These examples are provided by reviewers and are intended to be indicative rather than exhaustive. You may have other evidence that would be equally important and which support your case for excellence.

Criterion 4

Sustainability

The collaboration has sustained for at least three years and is anticipated to continue with/without funding.

Sub Criteria

Example of Evidence

4.1 The collaboration has had impact on the collaborators, their institutions, communities, and healthcare.

Narrative and/or information of the ways in which the collaborations has had impact. Include outputs/outcomes from the collaboration that reflect shared understanding and mutual benefit. 

Narrative description of the impact on individuals, programs, organizations, and where possible, the wider community (e.g., affiliated hospitals and clinics), with quantitative and qualitative data (e.g., student ratings of teaching and/or student performance assessment; recruitment of faculty members; achievements of students and faculty members; new faculty behaviours, roles, or responsibilities; list of educational publications and presentations; administrative strengthening to support projects).

You may place this list of publications and presentations in an appendix if it exceeds the word count.

4.2 The collaboration engages in on-going and systematic evaluation of outcomes and process.

Narrative description of the evaluation system, including types and frequency of data collected and synthesized, and an example of how findings are reported.

Includes a process to gather feedback on process, including decision-making processes, to ensure that views of all collaborators are included (and that any imbalances of power/influence are addressed).

4.3 The collaboration is resourced to sustain itself and/or allow partners to function independently.

Narrative description of how funding or “in kind” commitment will continue to sustain once any grant or soft funding expires. 

Indicate how capacity has been increased with the partners to continue independently for a specifically defined collaboration.

Provide explanations if funds will no longer be needed.

If any financial information is available to indicate viability or longer-term sustainability, this can be included but is not essential.


These examples are provided by reviewers and are intended to be indicative rather than exhaustive. You may have other evidence that would be equally important and which support your case for excellence.

Criterion 5

Scholarship

The collaboration has undertaken scholarship to inform others of outcomes and benefits of collaboration, including transferability and potential transformation.

Sub Criteria

Example of Evidence

5.1. The collaboration promotes educational innovation in practices, leadership and/or research.

Narrative description of collaborative products during the past five years with reference to evaluation reports and/or publications describing innovations and associated scholarship (if available).

5.2. The collaborators conduct evaluation and/or research related to their collaboration.

List of scholarly presentations and/or publications related to the collaboration in the past five years. You may place this list in an appendix if it exceeds the word count for Criterion 5.

5.3. The collaborators advance collaboration nationally and internationally.

List of awards, invitations to speak and consultations (e.g., to assist other institutions with collaboration and/or to be a collaborator) locally, nationally, and internationally in the past five years.

You may place this list in an appendix if it exceeds the word count for Criterion 5.


These examples are provided by reviewers and are intended to be indicative rather than exhaustive. You may have other evidence that would be equally important and which support your case for excellence.

Ready to apply?

Before deciding to submit an application, we recommend that you spend some time discussing the application criteria and required evidence with your team. If you have any questions, please reach out to us prior to submitting your application.

Please note that applications for this award must be submitted by a collaboration including higher education institutions which offer medical, dental, or veterinary programmes that are accredited according to the standards of its national agency. To be recognised as achieving excellence in International Collaboration, there must be evidence that includes the purposeful action of working with others for mutual benefit that extends beyond the organizations themselves and involves a sharing of responsibilities and power.

The collaboration must have been active for a substantial period (defined as three years or more) to be eligible for this award. This is an eligibility criterion that must be met. If there are unusual circumstances that are outside this definition of eligibility, please seek clarification from the panel chair.

Pricing

The standard charge per submission is £2,500 for each Area of Excellence to be assessed. This is reduced to £2,000 per submission for two or more submissions in the same twelve-month period. The charge for institutions from emerging economies is £1,500 per submission, and £1,250 for two or more submissions in the same calendar year. View the list of emerging economies to see if your institution is eligible. Payment must be received before submissions are sent out for review. Resubmissions are accepted within three years of the original application, with a charge of £2,000 for a resubmission.

Standard Charge

£2,500

Emerging Economies Charge

£1,500

Multiple Standard Submissions

£2,000 per submission
for two or more submissions
in the same twelve-month period.

Multiple Emerging Economies Submissions

£1,250 per submission
for two or more submissions
in the same twelve-month period.

Ready to apply?

Complete the form below to request an invoice.












Which ASPIRE Award(s) do you wish to apply for?









*Please note that to apply for the Inspirational and Innovative Approaches award, you must have submitted a letter of intent by Dec 18th and received an invitation to make a full application

Have you applied for an ASPIRE Award in the same area(s) in the last three years?